New trade deal presents landmark loss for Big Pharma
To satisfy House Democrats, the Trump administration removed a provision that would have given the makers of ultra-expensive biologic drugs 10 years of protection from less-expensive knockoffs.
Watch 6:47
The opioid industry fought hard to keep this database hidden. Here’s what it shows
Over the past two decades, hundreds of thousands of Americans have died during a national opioid addiction crisis. As the drug manufacturers face a possible legal reckoning from multiple lawsuits, a newly uncovered database sheds more light on the scope…
Voters don’t like ‘Big Pharma.’ But they could soon elect a Senate that includes two pharma lobbyists and a CEO
If Republicans prevail in just two races on Tuesday, the Senate’s ranks would suddenly include two former drug industry lobbyists and a pharma CEO.
Additional Support Provided By:
